BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15264964)

  • 1. Clinical effectiveness of atypical antipsychotics in dementia.
    Tariot PN
    J Clin Psychiatry; 2004; 65 Suppl 11():3-4. PubMed ID: 15264964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atypical antipsychotics in elderly patients with dementia].
    Selbaek G; Engedal K
    Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van Marum RJ; Jansen PA
    Ned Tijdschr Geneeskd; 2005 Jan; 149(4):165-7. PubMed ID: 15702733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    van der Mast RC
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726-7; author reply 727. PubMed ID: 15819141
    [No Abstract]   [Full Text] [Related]  

  • 5. [Increased risk of stroke during the use of olanzapine or risperidone in patients with dementia].
    Hafkamp GJ
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):726; author reply 727. PubMed ID: 15819140
    [No Abstract]   [Full Text] [Related]  

  • 6. A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.
    Shah A; Suh GH
    Int Psychogeriatr; 2005 Mar; 17(1):12-22; discussion 22-9. PubMed ID: 15945589
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical antipsychotics and risk of cerebrovascular accidents.
    Herrmann N; Mamdani M; Lanctôt KL
    Am J Psychiatry; 2004 Jun; 161(6):1113-5. PubMed ID: 15169702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term safety of risperidone.
    Davidson M
    J Clin Psychiatry; 2001; 62 Suppl 21():26-8. PubMed ID: 11584985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
    Yury CA; Fisher JE
    Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
    Layton D; Harris S; Wilton LV; Shakir SA
    J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSM warning on atypical psychotics and stroke may be detrimental for dementia.
    Mowat D; Fowlie D; MacEwan T
    BMJ; 2004 May; 328(7450):1262. PubMed ID: 15155521
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
    Tune LE
    J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychopharmacological treatment of behavioral and psychological symptoms in dementia].
    Lolk A; Gulmann NC
    Ugeskr Laeger; 2006 Oct; 168(40):3429-32. PubMed ID: 17032610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia.
    Lang DJ; Kopala LC; Vandorpe RA; Rui Q; Smith GN; Goghari VM; Lapointe JS; Honer WG
    Am J Psychiatry; 2004 Oct; 161(10):1829-36. PubMed ID: 15465980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
    Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of psychogeriatric patient.
    Zannino G; Gargiulo A; Lamenza F; Marotta MG; Barzotti T; Silvestri A; Ettorre E; Marigliano V
    Arch Gerontol Geriatr Suppl; 2004; (9):465-70. PubMed ID: 15207448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract]   [Full Text] [Related]  

  • 18. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms.
    Baskys A
    J Clin Psychiatry; 2004; 65 Suppl 11():16-22. PubMed ID: 15264967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
    Zaudig M
    Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive use of atypical antipsychotics and anticholinergic drugs among patients with schizophrenia.
    Ren XS; Huang YH; Lee AF; Miller DR; Qian S; Kazis L
    J Clin Pharm Ther; 2005 Feb; 30(1):65-71. PubMed ID: 15659005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.